State Street Corp Edesa Biotech, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.8 - $8.05 $15,840 - $159,390	19,800 Added 81.9%	43,975 $94,000
Q2 2022 Aug 15, 2022	BUY	$1.47 - $2.94 $1,911 - $3,822	1,300 Added 5.68%	24,175 $39,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $8.65 $46,530 - $77,850	9,000 Added 64.86%	22,875 $129,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $11.92 $58,275 - $165,390	13,875 New	13,875 $102,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $32.3M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.